Open Access Open Access  Restricted Access Subscription Access

Myeloperoxidase-463G/A Polymorphism in Patients with Diabetic Nephropathy in Sikkim, India


Affiliations
1 Department of Medical Biotechnology, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, India
2 Department of Medicine, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, India
3 Department of Biochemistry, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, India
 

Diabetic nephropathy (DN) is one of the most common causes of end-stage renal disease (ESRD). Despite major advances made in the area of diagnosis and treatment of DN, death cases related to this ailment are not significantly reduced. Thus it is important to identify the risk factors for this condition.
User
Notifications
Font Size

  • Singh, D. K., Winocour, P. and Farrington, K., Nature Rev. Endocrinol., 2011, 7, 176– 184.
  • Piedrafita, F. J., Molander, R. B., Vansant G, Orlova, E. A., Pfahl, M. and Reynolds, W. F., J. Biol. Chem., 1996, 271, 14412– 14420.
  • The Diabetes Control and Complications (DCCT) Research Group. Kidney Int., 1995, 47, 1703–1720.
  • Rovira-Llopis, S., Rocha, M., Falcon, R., de Pablo, C., Alvarez, A., Jover, A. and Hernandez-Milares, A., Antioxid. Redox Signal., 2013, 19, 1452–1458.
  • Ministry of Health and Family Welfare, Government of India, National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke 2013. Available from: pib.nic.in/newsite/PrintRelease.

Abstract Views: 501

PDF Views: 153




  • Myeloperoxidase-463G/A Polymorphism in Patients with Diabetic Nephropathy in Sikkim, India

Abstract Views: 501  |  PDF Views: 153

Authors

Rajit Mullick
Department of Medical Biotechnology, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, India
Sneha Sewa
Department of Medical Biotechnology, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, India
Parvati Nandy
Department of Medicine, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, India
T. Paras Singh
Department of Biochemistry, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, India
Arundhati Bag
Department of Medical Biotechnology, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, India

Abstract


Diabetic nephropathy (DN) is one of the most common causes of end-stage renal disease (ESRD). Despite major advances made in the area of diagnosis and treatment of DN, death cases related to this ailment are not significantly reduced. Thus it is important to identify the risk factors for this condition.

References





DOI: https://doi.org/10.18520/cs%2Fv117%2Fi11%2F1768-1769